AS_Hero_Contact

News & Insights

6 min read

Functional Assays: Narrowing the Field from Binders to Therapeutic Candidates

Candidate ID: How to go from hits to lead candidates

We tend to think of antibodies as being defined by their...

1 min read

Original Research: Targeting Three Spike Protein Domains Regulating SARS-CoV-2 Infectivity

Like our research colleagues across the entire global scientific community, our team here at Antibody Solutions...

4 min read

Peptides: The Less-is-More Strategy for Success

A strategic approach to peptide design yields success

When deciding which antigens to use for an antibody discovery...

7 min read

Animals are Still Vital for Antibody Discovery

If the last year has taught us anything, it’s that major biological threats can emerge seemingly out of nowhere,...

4 min read

Getting your antigen to stand out in the crowd

Here at Antibody Solutions, we believe that starting with the best possible input will yield the best possible output....

5 min read

Cell Fusion: A trusted tool that can still be an enigma

“Mystery is at the heart of creativity. That, and surprise.”  Julia Cameron

Hybridoma Cell Fusion 101 When it comes to...

2 min read

Modeling the Impact of the UK and South African Strain Mutations

Mutations Found in the South African and UK COVID-19 Virus Strains Improve the Stability of the ACE2-Spike RBD Complex

1 min read

Original Research: Generating Antibodies to SARS-CoV-2 Spike Protein Sites

As we’ve noted in some recent blog posts (here and here, for instance), our team at Antibody Solutions is joining the...

5 min read

Measure Twice, Cut Once: The Value of Target Analysis in Antibody Discovery

Editor’s note: Welcome to 2021, and to our first in a year-long series of posts that will explore the essentials in...

2 min read

The UK Strain and Other Recent RBD Mutations in the SARS-CoV-2 Virus

Examining mutations in the SARS-CoV-2 Spike (S) Protein Receptor Binding Domain (RBD) at the ACE2 receptor S protein...

5 min read

COVID-19 Targets, Tools and Therapeutics (Part 2)

Antibody Solutions is doing its part to respond to the COVID-19 pandemic, including original research, tool discovery,...

4 min read

Expanding the Repertoire of Antibody Drug Discovery with Lambda Light-Chain Models

Accessing the Untapped Potential of 33% of Human IgG

Harvard economist Michael Porter, PhD offers a clever observation...

3 min read

Global Spotlight Shines on mRNA Thanks to Pfizer, BioNTech COVID-19 Vaccine Candidate

In the science shot heard ‘round the world, Pfizer and BioNTech announced Monday that their vaccine candidate (aka...

3 min read

COVID-19 Targets, Tools and Therapeutics (Part 1)

Antibody Solutions is doing its part to respond to the COVID-19 pandemic, including original research, tool discovery,...

4 min read

Women Helping Women Power Through the Pandemic

On July 30th, we had the pleasure of moderating a virtual panel on Antibody Discovery and the Pandemic for the San...